Is GPGI a Buy? What to Consider in 2026
Short answer
The bull case for GPGI (GPGI) rests on CompoSecure card franchise: The legacy metal payment card business remains the crown jewel, ranked number one in its market alongside IDEMIA and Thales, and it delivered record sales and margin expansion in early 2026 under its Resolute Operating System. Market cap is ~$4.9B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: GPGI carries meaningful integration and financial risk after a roughly $5 billion acquisition, including a substantial debt load that makes deleveraging a stated first priority. Whether GPGI is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
GPGI, Inc. is a diversified holding company that trades on the NYSE under the ticker GPGI. It was formerly CompoSecure, the number-one maker of premium metal payment cards (it shipped over 30 million cards in 2025), and it rebranded to GPGI (short for Great Positions in Good Industries) in January 2026 after acquiring Husky Technologies, a global supplier of injection-molding systems and related plastics processing equipment, in a roughly $5 billion deal. The company now reports through two segments, CompoSecure and Husky, each with its own management team, and describes itself as a multi-industry platform designed to acquire and operate market-leading businesses. The investment picture is a tale of two businesses. CompoSecure continues to post record sales and margin expansion, while the newly added Husky segment has faced volume pressure, delayed projects, and margin compression tied to resin and oil price volatility, tariffs, and geopolitical disruption. In its first post-Husky quarter (Q1 2026), GPGI reported consolidated net sales around $408 million and adjusted EBITDA near $89 million, but a GAAP net loss of about $235 million driven largely by a $154 million loss on an equity-method investment. Management has said debt reduction is its first capital-allocation priority, targeting leverage below 3x adjusted EBITDA, so the near-term thesis is about integration execution and deleveraging rather than headline growth.
What's the case for buying GPGI?
1. CompoSecure card franchise
The legacy metal payment card business remains the crown jewel, ranked number one in its market alongside IDEMIA and Thales, and it delivered record sales and margin expansion in early 2026 under its Resolute Operating System. Premium metal cards for banks and fintechs give GPGI a differentiated, high-margin cash engine that funds the broader holding-company strategy.
2. Husky integration and margin recovery
Husky roughly triples the revenue base and adds exposure to packaging, beverage, and medical plastics equipment. The bull case rests on stabilizing Husky volumes and recovering its margins after a weak first quarter, which management attributes to project timing, resin and oil price swings, and tariff uncertainty rather than structural decline.
3. Deleveraging and the compounder model
Management has framed GPGI as a multi-industry compounder that acquires great positions in good industries, with the near-term focus squarely on paying down the debt taken on for the Husky deal and driving leverage below 3x adjusted EBITDA. Successful deleveraging would widen the runway for future acquisitions and reduce financial risk.
4. Fintech and security demand
Secular demand for premium payment products, authentication, and security solutions supports the CompoSecure side, while global packaging and consumer-goods trends underpin Husky. The combined platform aims to cross-pollinate operating discipline across cyclical and secular end markets.
What are the risks to GPGI?
GPGI carries meaningful integration and financial risk after a roughly $5 billion acquisition, including a substantial debt load that makes deleveraging a stated first priority. The first post-Husky quarter swung to a GAAP net loss of about $235 million, driven largely by a $154 million equity-method investment loss, and the stock fell sharply on the mixed results. Husky is exposed to cyclical industrial demand, resin and oil price volatility, tariffs, and geopolitical disruption, any of which can pressure margins. The complex accounting (with part of the transaction treated as an equity-method investment) makes reported GAAP figures harder to interpret. As a recently reorganized multi-segment holding company, execution risk on integration and capital allocation is elevated relative to the old single-business CompoSecure.
How is GPGI valued? (as of JULY 2026)
Snapshot for GPGI as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Market cap: ~$4.9B
- Q1 2026 consolidated net sales: ~$408M
- Q1 2026 pro forma adjusted net sales: ~$421M
- Q1 2026 adjusted EBITDA: ~$89M
- Q1 2026 GAAP net loss: ~-$235M
- CompoSecure FY2025 net sales: ~$462M
GPGI now runs at a much larger combined revenue base than the old CompoSecure, roughly $1.6 billion annualized once Husky is included, but its first post-Husky quarter produced a large GAAP net loss driven by a $154 million equity-method investment loss rather than operating collapse. Because reported earnings are distorted by acquisition accounting and a heavy debt load, some analysts lean on measures like price-to-book and adjusted EBITDA instead of standard P/E. Consensus price targets in mid-2026 clustered in the low-to-mid $20s with a broadly constructive tone, though estimates vary widely given the recency of the combination.
How do you decide if GPGI is a buy?
Rather than asking whether GPGI is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold GPGI indirectly through an index or sector ETF before adding more.
For the full picture, see the GPGI stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about GPGI against your real portfolio and see your actual exposure before deciding.
The bottom line on GPGI
The bottom line: GPGI's story right now is CompoSecure card franchise, with market cap at ~$4.9B. If you believe that narrative continues, the call is about sizing GPGI sensibly and checking overlap with what you own; if you doubt it (the risk: gPGI carries meaningful integration and financial risk after a roughly $5 billion acquisition, including a substantial debt load that makes deleveraging a stated first priority.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around GPGI with Walnut
Use GPGI as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is GPGI a good stock to buy right now?
+
The case for GPGI right now is CompoSecure card franchise, with market cap at ~$4.9B. If you believe that thesis holds, GPGI is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is gPGI carries meaningful integration and financial risk after a roughly $5 billion acquisition, including a substantial debt load that makes deleveraging a stated first priority. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does GPGI do?
+
GPGI, Inc.
What are the main risks of GPGI?
+
GPGI carries meaningful integration and financial risk after a roughly $5 billion acquisition, including a substantial debt load that makes deleveraging a stated first priority. The first post-Husky quarter swung to a GAAP net loss of about $235 million, driven largely by a $154 million equity-method investment loss, and the stock fell sharply on the mixed results. Husky is exposed to cyclical industrial demand, resin and oil price volatility, tariffs, and geopolitical disruption, any of which can pressure margins. The complex accounting (with part of the transaction treated as an equity-method investment) makes reported GAAP figures harder to interpret. As a recently reorganized multi-segment holding company, execution risk on integration and capital allocation is elevated relative to the old single-business CompoSecure.
What company is GPGI?
+
GPGI, Inc. is a NYSE-listed diversified holding company formerly known as CompoSecure. It rebranded to GPGI (Great Positions in Good Industries) in January 2026 after combining its metal payment card business with Husky Technologies, a plastics injection-molding equipment maker.
Is GPGI the same as CompoSecure?
+
Yes. CompoSecure changed its name to GPGI, Inc. and began trading under the GPGI ticker at the open on January 23, 2026. CompoSecure now operates as one of GPGI's two reporting segments, alongside Husky.
What does GPGI do?
+
Through its CompoSecure segment it makes premium metal payment cards, security, and authentication products for banks and fintechs, and through its Husky segment it supplies injection-molding systems and related plastics processing equipment worldwide. GPGI operates as a multi-industry holding company across both.
What was the Husky acquisition?
+
In late 2025 GPGI agreed to acquire Husky Technologies for roughly $5 billion in cash and stock, supported by a large PIPE financing, and the deal closed in January 2026. It roughly tripled the company's revenue base and reshaped it into a diversified platform.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell GPGI; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.